Literature DB >> 20454805

Trypanosoma cruzi infection: do distinct populations cause intestinal motility alteration?

Monica de Melo Medeiros1, Tania C Araújo-Jorge, Wanderson S Batista, Tshaca Mahatma Oara Alves da Silva, Andréa Pereira de Souza.   

Abstract

Chagas disease, caused by Trypanosoma cruzi, is an important public health problem in Latin America. Disturbances in gastrointestinal motility are observed in 15-20% of patients at the chronic phase. We previously observed a decrease in intestinal motility in mice infected with Y strain from T. cruzi. Thus, we decided to test if infection with other T. cruzi strains also caused the intestinal disturbance. Male adult Swiss mice were infected intraperitoneally with CL-Brener clone (CL-B), Brazil strain (Br), or Dm28 clone (Dm) of T. cruzi. All infected mice presented a low cumulative mortality (CL-B, 17%; Br, 8%; Dm, 25%) at 35 days post infection (dpi) and their typical parasitemia curves. Br and Dm groups exhibited a maximal reduction of intestinal motility at 35 dpi (176.8 +/- 51.3 and 198.3 +/- 52.6 min, respectively), when compared with non-infected mice (90.2 +/- 19.5 min). However, CL mice presented the peak of delayed intestinal transit at 12 dpi (191.0 +/- 33.3 min), when compared with non-infected mice (105.6 +/- 26.4 min), very close to the 15 dpi for the intense alteration (310.2 +/- 67.4 min) observed with the Y strain. We clearly demonstrate a reduction in intestinal motility in mice infected with different groups of T. cruzi during the acute phase of the infection. Since Br, Dm, and CL strains presented low mortality rates in adult Swiss mice, a prospective study concerning the chronic intestinal alteration is encouraged, particularly for studies of alternative therapies.

Entities:  

Mesh:

Year:  2010        PMID: 20454805     DOI: 10.1007/s00436-010-1871-5

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  22 in total

1.  Neuron count reevaluation in the myenteric plexus of chagasic megacolon after morphometric neuron analysis.

Authors:  S J Adad; C G Cançado; R M Etchebehere; V P Teixeira; U A Gomes; E Chapadeiro; E R Lopes
Journal:  Virchows Arch       Date:  2001-03       Impact factor: 4.064

2.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi.

Authors:  Z BRENER
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1962 Nov-Dec       Impact factor: 1.846

3.  Protocol to refine intestinal motility test in mice.

Authors:  Hérida Regina Nunes Marona; Maria Beatriz Bastos Lucchesi
Journal:  Lab Anim       Date:  2004-07       Impact factor: 2.471

Review 4.  Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis.

Authors:  F Köberle
Journal:  Adv Parasitol       Date:  1968       Impact factor: 3.870

5.  Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-n-propylquinoline.

Authors:  H Nakayama; M E Ferreira; A Rojas de Arias; N Vera de Bilbao; S Torres; A Schinini; A Fournet
Journal:  Phytother Res       Date:  2001-11       Impact factor: 5.878

6.  Infection with different Trypanosoma cruzi populations in rats: myocarditis, cardiac sympathetic denervation, and involvement of digestive organs.

Authors:  E R Camargos; D J Franco; C M Garcia; A P Dutra; A L Teixeira; E Chiari; C R Machado
Journal:  Am J Trop Med Hyg       Date:  2000-05       Impact factor: 2.345

7.  A magnetic resonance imaging study of intestinal dilation in Trypanosoma cruzi-infected mice deficient in nitric oxide synthase.

Authors:  Lars Ny; Hua Li; Shankar Mukherjee; Katarina Persson; Bo Holmqvist; Dazhi Zhao; Vitaliy Shtutin; Huan Huang; Louis M Weiss; Fabiana S Machado; Stephen M Factor; John Chan; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

8.  Applicability of the use of charcoal for the evaluation of intestinal motility in a murine model of Trypanosoma cruzi infection.

Authors:  Gabriel Melo de Oliveira; Monica de Melo Medeiros; Wanderson da Silva Batista; Renata Santana; Tania C Araújo-Jorge; Andréa Pereira de Souza
Journal:  Parasitol Res       Date:  2007-12-28       Impact factor: 2.289

9.  Glial fibrillary acidic protein and S-100 colocalization in the enteroglial cells in dilated and nondilated portions of colon from chagasic patients.

Authors:  Alexandre B M da Silveira; Michelle A R Freitas; Enio C de Oliveira; Salustiano G Neto; Alejandro O Luquetti; John B Furness; Rodrigo Correa-Oliveira; Débora d'Avila Reis
Journal:  Hum Pathol       Date:  2008-10-05       Impact factor: 3.466

10.  Interferon-gamma-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice.

Authors:  Rosa M E Arantes; Homero H F Marche; Maria T Bahia; Fernando Q Cunha; Marcos A Rossi; João S Silva
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

View more
  3 in total

1.  In vivo imaging of mice infected with bioluminescent Trypanosoma cruzi unveils novel sites of infection.

Authors:  Cristina Henriques; Andréa Henriques-Pons; Marcelo Meuser-Batista; Aline Salgado Ribeiro; Wanderley de Souza
Journal:  Parasit Vectors       Date:  2014-03-03       Impact factor: 3.876

2.  Enteric Neuronal Damage, Intramuscular Denervation and Smooth Muscle Phenotype Changes as Mechanisms of Chagasic Megacolon: Evidence from a Long-Term Murine Model of Trypanosoma cruzi Infection.

Authors:  Camila França Campos; Silvia Dantas Cangussú; Ana Luiza Cassin Duz; Christiane Teixeira Cartelle; Maria de Lourdes Noviello; Vanja Maria Veloso; Maria Terezinha Bahia; Camila Megale Almeida-Leite; Rosa Maria Esteves Arantes
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

3.  The Influence of Recombinational Processes to Induce Dormancy in Trypanosoma cruzi.

Authors:  Bruno Carvalho Resende; Anny Carolline Silva Oliveira; Anna Carolina Paganini Guañabens; Bruno Marçal Repolês; Verônica Santana; Priscila Mazzochi Hiraiwa; Sérgio Danilo Junho Pena; Glória Regina Franco; Andrea Mara Macedo; Erich Birelli Tahara; Stênio Perdigão Fragoso; Luciana Oliveira Andrade; Carlos Renato Machado
Journal:  Front Cell Infect Microbiol       Date:  2020-01-28       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.